Trials / Completed
CompletedNCT05065762
Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment
Patient Preference for Treatment of Moderate-To-Severe Psoriasis in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 232 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to identify and weight the treatment attributes from the moderate-to-severe Psoriasis (PsO) patients' perspective in Japan.
Conditions
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2022-02-07
- Completion
- 2022-02-07
- First posted
- 2021-10-04
- Last updated
- 2022-06-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05065762. Inclusion in this directory is not an endorsement.